✦ LIBER ✦

PND21 FIRST USE OF DISEASE-MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS

✍ Scribed by DM Meletiche; C Kozma; M Dickson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND45 USE OF DISEASE-MODIFYING DRUGS IN

✍ K Noyes; A Bajorska; S Schwid; R Holloway; A Dick 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Postmarketing evidence of disease-modify

✍ Maria Trojano; Damiano Paolicelli; Aurora Fuiani; Fabio Pellegrini; Pietro Iaffa 📂 Article 📅 2008 🏛 Springer Milan 🌐 English ⚖ 33 KB

Long-term experience with current diseas

✍ Corey C. Ford 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 321 KB

PND11 NURSE COSTING SURVEY FOR THE MANAG

✍ R Perard; L Parkes 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PND23 PREVALENCE OF TREATMENT GAPS IN MU

✍ C Fincher; C Kozma; DM Meletiche; M Dickson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PND16 ECONOMIC IMPACT OF DISEASE-MODIFYI

✍ JJ Stephenson; S Kamat; C Cai; K Rajagopalan; S Agarwal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB